Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

exoplan

K-Number: K213302 · 2022-05-03

ApplicantExocad GmbH
Decision Date2022-05-03
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

exoplan is a medical device manufactured by Exocad GmbH. It received FDA 510(k) clearance on 2022-05-03 under approval number K213302. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the exoplan?

exoplan is a medical device that received FDA 510(k) clearance on 2022-05-03. It is manufactured by Exocad GmbH. The 510(k) number is K213302.

When was exoplan approved by the FDA?

exoplan received FDA 510(k) clearance on 2022-05-03, under approval number K213302.

What company makes exoplan?

exoplan is manufactured by Exocad GmbH.

What is the FDA product code for exoplan?

The FDA product code for exoplan is LLZ.

Other Devices by Exocad GmbH

K183458exoplan 2.3 K193352AbutmentCAD

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑